Scotts Miracle-Gro (SMG) Financials

$54.95 -1.20 (-2.14%)

Closing price 05/6/2025 03:59 PM Eastern

Extended Trading

$55.30 +0.35 (+0.65%)

As of 08:02 AM Eastern

Annual Income Statements for Scotts Miracle-Gro

This table shows Scotts Miracle-Gro's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Net Income / (Loss) Attributable to Common Shareholders	160	315	218	64	461	387	513	-438	-380	-35
Consolidated Net Income / (Loss)	159	315	219	64	460	389	513	-438	-380	-35
Net Income / (Loss) Continuing Operations	129	246	198	128	437	387	517	-438	-380	-35
Total Pre-Tax Income	205	384	315	116	582	511	677	-558	-453	-24
Total Operating Income	254	448	433	199	410	585	723	-434	-174	209
Total Gross Profit	811	900	973	865	1,020	1,347	1,469	873	657	851
Total Revenue	2,371	2,506	2,642	2,663	3,156	4,132	4,925	3,924	3,551	3,553
Operating Revenue	2,371	2,506	2,642	2,663	3,156	4,132	4,925	3,924	3,551	3,553
Total Cost of Revenue	1,560	1,606	1,670	1,799	2,136	2,785	3,456	3,051	2,894	2,702
Operating Cost of Revenue	1,557	1,600	1,670	1,778	2,131	2,769	3,431	2,891	2,708	2,619
Other Cost of Revenue	3.00	5.90	0.00	21	5.90	16	25	160	186	84
Total Operating Expenses	557	453	539	666	610	762	746	1,307	832	642
Selling, General & Admin Expense	489	518	551	540	601	758	744	613	551	559
Other Operating Expenses / (Income)	-2.20	-14	-17	-6.70	1.30	3.20	-1.80	0.80	-0.10	20
Restructuring Charge	70	-52	4.90	132	7.40	0.80	4.30	693	281	63
Total Other Income / (Expense), net	-49	-64	-119	-83	172	-75	-46	-124	-279	-232
Interest Expense	49	72	76	86	102	95	79	118	178	159
Interest & Investment Income	0.00	7.80	-29	4.90	3.30	0.00	14	-13	-101	-68
Other Income / (Expense), net	0.00	0.00	-13	-1.70	271	20	19	6.90	0.30	-5.50
Income Tax Expense	76	138	117	-12	145	124	160	-121	-73	11
Basic Earnings per Share	$2.62	$5.16	$3.68	$1.13	$8.30	$6.96	$9.20	($7.88)	($6.79)	($0.61)
Weighted Average Basic Shares Outstanding	61.10M	61.10M	59.40M	56.20M	55.82M	55.74M	55.16M	55.46M	56.55M	57.41M
Diluted Earnings per Share	$2.57	$5.09	$3.63	$1.12	$8.18	$6.81	$8.96	($7.88)	($6.79)	($0.61)
Weighted Average Diluted Shares Outstanding	61.10M	61.10M	59.40M	56.20M	55.82M	55.74M	55.16M	55.46M	56.55M	57.41M
Weighted Average Basic & Diluted Shares Outstanding	61.10M	61.10M	59.40M	56.20M	55.82M	55.74M	55.16M	55.46M	56.55M	57.41M
Cash Dividends to Common per Share	$1.82	$1.91	$2.03	$2.14	$2.23	$7.36	$2.52	$2.64	$2.64	$2.64

This table shows Scotts Miracle-Gro's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	7/2/2022	9/30/2022	12/31/2022	4/1/2023	7/1/2023	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/30/2024	12/28/2024
Net Income / (Loss) Attributable to Common Shareholders	-444	-220	-65	109	44	-469	-81	158	132	-244	-70
Consolidated Net Income / (Loss)	-444	-220	-65	109	44	-469	-81	158	132	-244	-70
Net Income / (Loss) Continuing Operations	-444	-220	-65	109	44	-469	-81	158	132	-244	-70
Total Pre-Tax Income	-577	-272	-94	150	52	-561	-114	220	183	-312	-96
Total Operating Income	-563	-224	-42	206	77	-416	-47	272	200	-216	-51
Total Gross Profit	237	-71	96	413	206	-57	62	464	354	-30	95
Total Revenue	1,186	494	527	1,532	1,119	375	410	1,525	1,202	415	417
Operating Revenue	1,186	494	527	1,532	1,119	375	410	1,525	1,202	415	417
Total Cost of Revenue	950	564	431	1,119	913	432	348	1,062	848	444	322
Operating Cost of Revenue	884	475	421	1,000	880	408	354	987	851	427	317
Other Cost of Revenue	66	89	10	119	33	24	-5.80	75	-2.50	17	5.10
Total Operating Expenses	799	153	138	207	129	359	110	192	154	187	146
Selling, General & Admin Expense	136	118	129	186	129	108	115	179	148	118	125
Other Operating Expenses / (Income)	4.90	2.00	0.50	-1.60	-1.60	2.60	1.80	11	6.90	0.40	4.50
Restructuring Charge	658	33	8.50	22	1.70	249	-7.10	2.10	-0.80	69	17
Total Other Income / (Expense), net	-14	-48	-53	-56	-25	-145	-67	-52	-17	-96	-45
Interest Expense	31	35	43	48	47	40	43	44	39	33	34
Interest & Investment Income	15	-14	-11	-7.30	22	-105	-23	-7.00	23	-62	-9.90
Other Income / (Expense), net	1.70	1.50	1.60	-0.80	-0.40	-0.10	-1.60	-1.20	-1.30	-1.40	-1.30
Income Tax Expense	-133	-52	-30	40	8.30	-92	-34	62	51	-68	-26
Basic Earnings per Share	($8.01)	($3.95)	($1.17)	$1.95	$0.78	($8.35)	($1.42)	$2.77	$2.33	($4.29)	($1.21)
Weighted Average Basic Shares Outstanding	55.40M	55.46M	55.50M	56M	56.20M	56.55M	56.70M	56.80M	56.80M	57.41M	57.30M
Diluted Earnings per Share	($8.01)	($3.91)	($1.17)	$1.94	$0.77	($8.33)	($1.42)	$2.74	$2.28	($4.21)	($1.21)
Weighted Average Diluted Shares Outstanding	55.40M	55.46M	55.50M	56.50M	56.60M	56.55M	56.70M	57.40M	58M	57.41M	57.30M
Weighted Average Basic & Diluted Shares Outstanding	55.41M	55.46M	55.96M	56.07M	56.16M	56.55M	56.69M	56.80M	56.82M	57.41M	57.47M
Cash Dividends to Common per Share	$0.66	-	$0.66	$0.66	$0.66	-	$0.66	-	$0.66	-	$0.66

This table details how cash moves in and out of Scotts Miracle-Gro's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Net Change in Cash & Equivalents	-18	-21	70	-87	-15	-2.20	228	-157	-55	40
Net Cash From Operating Activities	247	244	363	343	227	558	272	-129	531	668
Net Cash From Continuing Operating Activities	247	244	363	343	227	558	272	-129	531	668
Net Income / (Loss) Continuing Operations	159	315	219	64	460	389	513	-438	-380	-35
Consolidated Net Income / (Loss)	159	315	219	64	460	389	513	-438	-380	-35
Depreciation Expense	51	54	55	53	56	62	63	68	67	65
Amortization Expense	18	20	25	30	33	33	31	37	25	16
Non-Cash Adjustments To Reconcile Net Income	18	-114	24	169	-224	73	38	714	459	233
Changes in Operating Assets and Liabilities, net	1.70	-30	40	27	-99	1.70	-374	-511	360	389
Net Cash From Investing Activities	-536	-134	22	-581	255	47	-539	-283	-66	-100
Net Cash From Continuing Investing Activities	-536	-134	22	-581	255	47	-539	-283	-66	-100
Purchase of Property, Plant & Equipment	-62	-58	-70	-68	-42	-63	-107	-114	-93	-84
Acquisitions	-480	-183	-122	-528	-6.60	0.00	-128	-237	0.00	-21
Purchase of Investments	0.00	-	-	-	0.00	-3.40	-295	-25	0.00	0.00
Sale of Property, Plant & Equipment	5.50	2.40	5.70	5.10	2.10	116	0.20	63	2.50	2.40
Other Investing Activities, net	0.00	-90	-30	11	7.00	-2.90	-8.70	29	25	2.60
Net Cash From Financing Activities	279	-129	-317	151	-497	-607	494	255	-520	-528
Net Cash From Continuing Financing Activities	279	-129	-317	151	-497	-607	494	255	-520	-528
Repayment of Debt	-1,460	-2,364	-1,651	-2,328	-1,447	-1,833	-1,375	-2,941	-1,700	-1,024
Repurchase of Common Equity	-15	-137	-255	-398	-3.10	-53	-129	-258	-9.30	-5.10
Payment of Dividends	-111	-117	-128	-120	-125	-411	-143	-166	-149	-151
Issuance of Debt	1,836	2,469	1,449	2,987	1,056	1,673	2,143	3,617	1,336	649
Other Financing Activities, net	29	21	269	11	21	18	-2.30	3.30	2.30	3.80
Other Net Changes in Cash	-	-	1.60	-	-	0.00	0.60	-	-0.10	0.50

This table details how cash moves in and out of Scotts Miracle-Gro's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	7/2/2022	9/30/2022	12/31/2022	4/1/2023	7/1/2023	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/30/2024	12/28/2024
Net Change in Cash & Equivalents	11	59	-61	-0.60	2.40	4.50	-22	55	215	-208	-62
Net Cash From Operating Activities	463	551	-432	-135	563	535	-343	304	588	119	-445
Net Cash From Continuing Operating Activities	463	551	-432	-135	563	535	-343	304	588	119	-445
Net Income / (Loss) Continuing Operations	-444	-220	-65	109	44	-468	-81	158	132	-244	-70
Consolidated Net Income / (Loss)	-444	-220	-65	109	44	-468	-81	158	132	-244	-70
Depreciation Expense	18	18	18	16	16	18	16	16	17	16	16
Amortization Expense	9.20	8.60	7.70	6.40	6.70	4.40	4.00	3.90	3.90	3.90	3.10
Non-Cash Adjustments To Reconcile Net Income	628	45	36	85	-22	359	39	41	-1.10	154	38
Changes in Operating Assets and Liabilities, net	252	699	-428	-352	519	622	-322	86	437	188	-433
Net Cash From Investing Activities	-79	51	-36	15	-24	-21	-53	-18	-8.90	-20	-23
Net Cash From Continuing Investing Activities	-79	51	-36	15	-24	-21	-53	-18	-8.90	-20	-23
Purchase of Property, Plant & Equipment	-33	-15	-30	-22	-22	-19	-38	-16	-13	-17	-29
Acquisitions	-35	-	-	-	-	-	-21	-	-	-	0.00
Other Investing Activities, net	13	12	-6.40	0.60	-2.00	32	6.10	-1.60	4.30	-6.20	6.00
Net Cash From Financing Activities	-373	-543	406	119	-536	-509	374	-231	-364	-307	408
Net Cash From Continuing Financing Activities	-373	-543	406	119	-536	-509	374	-231	-364	-307	408
Repayment of Debt	-2,167	-684	-203	-385	-600	-512	-31	-266	-456	-271	-63
Repurchase of Common Equity	-1.30	-0.20	-0.80	-5.60	-2.90	-	-3.10	-1.80	-0.10	-0.10	-16
Payment of Dividends	-36	-37	-37	-38	-37	-37	-37	-39	-38	-38	-39
Issuance of Debt	1,830	177	646	548	103	40	445	74	129	-	525
Other Financing Activities, net	0.80	0.70	0.60	0.60	0.50	0.60	0.50	1.20	0.70	1.40	0.70
Effect of Exchange Rate Changes	-0.20	-0.30	0.20	0.20	0.10	-	-	-0.20	-0.40	-	-0.90

This table presents Scotts Miracle-Gro's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Total Assets	2,527	2,756	2,747	3,055	3,029	3,381	4,800	4,297	3,414	2,872
Total Current Assets	1,119	1,033	882	886	1,042	1,217	2,024	1,982	1,398	980
Cash & Equivalents	71	29	121	34	19	17	244	87	32	72
Accounts Receivable	158	127	198	226	224	475	483	379	304	177
Inventories, net	396	395	408	481	540	622	1,127	1,344	880	588
Prepaid Expenses	121	52	67	60	174	81	170	173	181	145
Plant, Property, & Equipment, net	444	445	468	531	546	0.00	622	606	610	610
Total Noncurrent Assets	964	1,278	1,398	1,638	1,441	2,164	2,154	1,709	1,406	1,282
Long-Term Investments	0.00	101	31	36	-	0.00	207	194	92	45
Goodwill	284	372	442	543	539	544	605	254	244	244
Intangible Assets	655	690	749	857	708	679	710	580	437	419
Other Noncurrent Operating Assets	25	115	176	202	195	941	632	681	633	574
Total Liabilities & Shareholders' Equity	2,527	2,756	2,747	3,055	3,029	3,381	4,800	4,297	3,414	2,872
Total Liabilities	1,894	2,022	2,085	2,695	2,306	2,678	3,787	4,149	3,681	3,263
Total Current Liabilities	619	707	545	613	621	950	1,140	964	774	750
Short-Term Debt	133	185	143	133	128	66	58	144	52	53
Accounts Payable	193	131	153	151	214	391	609	423	271	255
Other Current Liabilities	251	178	248	330	278	493	473	397	450	443
Total Noncurrent Liabilities	1,276	1,314	1,541	2,082	1,685	1,727	2,646	3,185	2,907	2,512
Long-Term Debt	1,025	1,031	1,258	1,884	1,524	1,455	2,237	2,826	2,557	2,174
Other Noncurrent Operating Liabilities	251	284	283	198	162	272	410	359	350	338
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	633	734	662	360	723	703	1,013	148	-267	-391
Total Preferred & Common Equity	621	715	649	355	719	697	1,013	148	-267	-391
Total Common Equity	621	715	649	355	719	697	1,013	148	-267	-391
Common Stock	400	402	408	420	442	483	477	364	353	362
Retained Earnings	684	882	978	920	1,275	1,236	1,605	1,020	491	304
Treasury Stock	-357	-451	-668	-940	-904	-922	-1,002	-1,092	-999	-949
Accumulated Other Comprehensive Income / (Loss)	-107	-117	-69	-46	-94	-99	-66	-145	-113	-107

This table presents Scotts Miracle-Gro's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	7/2/2022	12/31/2022	4/1/2023	7/1/2023	12/30/2023	3/30/2024	6/29/2024	12/28/2024
Total Assets	4,994	4,534	4,988	4,454	3,716	3,924	3,489	3,170
Total Current Assets	2,589	2,299	2,842	2,251	1,681	1,935	1,538	1,285
Cash & Equivalents	28	26	25	27	10	65	280	9.80
Accounts Receivable	953	490	1,458	1,160	288	877	505	214
Inventories, net	1,408	1,526	1,128	885	1,170	824	607	910
Prepaid Expenses	201	258	232	179	214	169	147	152
Plant, Property, & Equipment, net	625	593	589	590	610	608	599	607
Total Noncurrent Assets	1,780	1,642	1,557	1,613	1,424	1,381	1,352	1,278
Long-Term Investments	208	182	174	197	91	84	107	46
Goodwill	255	254	254	255	244	244	244	244
Intangible Assets	627	576	566	560	433	429	425	415
Other Noncurrent Operating Assets	690	630	563	602	656	624	576	573
Total Liabilities & Shareholders' Equity	4,994	4,534	4,988	4,454	3,716	3,924	3,489	3,170
Total Liabilities	4,576	4,475	4,851	4,320	4,102	4,175	3,636	3,650
Total Current Liabilities	1,072	932	1,373	1,329	764	1,060	854	684
Short-Term Debt	322	217	435	451	55	58	53	55
Accounts Payable	291	367	416	366	333	440	317	309
Other Current Liabilities	459	348	522	513	377	562	485	320
Total Noncurrent Liabilities	3,504	3,543	3,478	2,991	3,337	3,115	2,781	2,966
Long-Term Debt	3,156	3,190	3,138	2,629	2,969	2,761	2,436	2,637
Other Noncurrent Operating Liabilities	348	353	340	362	368	354	345	329
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	418	60	138	135	-385	-251	-146	-480
Total Preferred & Common Equity	418	60	138	135	-385	-251	-146	-480
Total Common Equity	418	60	138	135	-385	-251	-146	-480
Common Stock	362	368	374	351	350	354	361	349
Retained Earnings	1,277	918	990	997	372	492	586	196
Treasury Stock	-1,096	-1,057	-1,040	-1,032	-986	-978	-976	-920
Accumulated Other Comprehensive Income / (Loss)	-125	-169	-187	-181	-122	-119	-117	-105

This table displays calculated financial ratios and metrics derived from Scotts Miracle-Gro's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-8.04%	5.70%	5.42%	0.81%	18.50%	30.91%	19.20%	-20.32%	-9.50%	0.04%
EBITDA Growth	-7.27%	61.43%	-4.03%	-43.89%	174.20%	-9.02%	19.34%	-138.53%	74.65%	447.92%
EBIT Growth	-10.54%	76.36%	-6.17%	-53.05%	244.88%	-11.00%	22.52%	-157.59%	59.24%	216.77%
NOPAT Growth	-12.88%	80.17%	-4.93%	-19.63%	40.21%	44.18%	24.57%	-155.00%	59.82%	219.72%
Net Income Growth	-4.51%	98.36%	-30.50%	-70.89%	622.45%	-15.56%	32.12%	-185.22%	13.12%	90.82%
EPS Growth	-3.02%	98.05%	-28.68%	-69.15%	630.36%	-16.75%	31.57%	-187.95%	13.83%	91.02%
Operating Cash Flow Growth	2.49%	-1.17%	48.85%	-5.70%	-33.78%	146.03%	-51.34%	-147.51%	511.63%	25.71%
Free Cash Flow Firm Growth	-265.76%	142.28%	176.12%	-226.11%	246.80%	129.71%	-116.32%	-194.93%	274.54%	29.87%
Invested Capital Growth	22.06%	15.36%	7.53%	20.66%	2.17%	-6.29%	29.39%	-0.67%	-21.81%	-22.50%
Revenue Q/Q Growth	-8.47%	4.18%	13.02%	2.20%	2.06%	10.50%	-3.00%	-5.86%	-3.24%	1.14%
EBITDA Q/Q Growth	-4.86%	4.64%	0.46%	-26.83%	13.75%	12.41%	-6.72%	-133.43%	-170.10%	225.20%
EBIT Q/Q Growth	-6.83%	5.27%	0.29%	-34.79%	15.90%	13.91%	-7.29%	-77.59%	-988.27%	4,319.57%
NOPAT Q/Q Growth	-9.00%	6.45%	1.11%	-28.35%	31.46%	12.09%	-6.12%	-75.57%	-1,085.31%	2,272.73%
Net Income Q/Q Growth	-5.37%	-0.73%	-2.89%	-64.05%	23.91%	19.09%	-9.21%	-64.91%	-188.61%	86.55%
EPS Q/Q Growth	-4.10%	-1.17%	-3.46%	-64.44%	23.19%	19.26%	-9.22%	-63.83%	-186.50%	87.10%
Operating Cash Flow Q/Q Growth	6.98%	25.90%	-0.36%	27.70%	-15.44%	60.81%	-11.97%	35.82%	-2.80%	-38.44%
Free Cash Flow Firm Q/Q Growth	-208.63%	112.76%	-53.24%	43.67%	-12.89%	43.22%	-140.04%	64.74%	-27.09%	-37.96%
Invested Capital Q/Q Growth	2.54%	-17.99%	-10.67%	-16.36%	-12.60%	-17.56%	-5.57%	-22.46%	-25.81%	-12.11%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	34.20%	35.92%	36.81%	32.46%	32.31%	32.60%	29.83%	22.24%	18.51%	23.94%
EBITDA Margin	13.61%	20.79%	18.93%	10.54%	24.38%	16.94%	16.96%	-8.20%	-2.30%	7.99%
Operating Margin	10.70%	17.86%	16.40%	7.47%	12.98%	14.16%	14.68%	-11.06%	-4.91%	5.88%
EBIT Margin	10.70%	17.86%	15.90%	7.40%	21.55%	14.65%	15.06%	-10.88%	-4.90%	5.72%
Profit (Net Income) Margin	6.69%	12.56%	8.28%	2.39%	14.58%	9.41%	10.42%	-11.15%	-10.70%	-0.98%
Tax Burden Percent	77.41%	82.04%	69.48%	55.06%	79.13%	76.11%	75.82%	78.39%	83.85%	147.88%
Interest Burden Percent	80.77%	85.72%	74.98%	58.67%	85.52%	84.35%	91.30%	130.67%	260.37%	-11.61%
Effective Tax Rate	37.22%	35.86%	37.03%	-10.29%	24.91%	24.23%	23.60%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	11.37%	17.30%	14.80%	10.40%	13.19%	19.43%	21.81%	-10.67%	-4.83%	7.42%
ROIC Less NNEP Spread (ROIC-NNEP)	11.29%	20.15%	10.08%	0.66%	21.72%	15.94%	19.49%	-16.57%	-14.80%	-0.46%
Return on Net Nonoperating Assets (RNNOA)	15.07%	28.74%	16.55%	2.07%	71.81%	35.07%	38.02%	-64.70%	640.45%	3.19%
Return on Equity (ROE)	26.44%	46.04%	31.35%	12.47%	85.00%	54.50%	59.83%	-75.37%	635.62%	10.61%
Cash Return on Invested Capital (CROIC)	-8.50%	3.04%	7.54%	-8.32%	11.05%	25.93%	-3.81%	-10.00%	19.66%	32.78%
Operating Return on Assets (OROA)	11.07%	16.94%	15.27%	6.80%	22.36%	18.89%	18.13%	-9.39%	-4.52%	6.47%
Return on Assets (ROA)	6.92%	11.92%	7.95%	2.20%	15.13%	12.13%	12.55%	-9.62%	-9.86%	-1.11%
Return on Common Equity (ROCE)	25.87%	44.98%	30.63%	12.26%	84.26%	54.11%	59.63%	-75.37%	635.62%	10.61%
Return on Equity Simple (ROE_SIMPLE)	25.57%	44.02%	33.72%	17.96%	64.03%	55.74%	50.67%	-296.21%	142.20%	8.94%
Net Operating Profit after Tax (NOPAT)	159	287	273	219	308	443	552	-304	-122	146
NOPAT Margin	6.72%	11.46%	10.33%	8.24%	9.75%	10.73%	11.22%	-7.74%	-3.44%	4.11%
Net Nonoperating Expense Percent (NNEP)	0.08%	-2.84%	4.72%	9.74%	-8.53%	3.49%	2.33%	5.90%	9.97%	7.88%
Cost of Revenue to Revenue	65.80%	64.08%	63.19%	67.54%	67.69%	67.40%	70.17%	77.76%	81.49%	76.06%
SG&A Expenses to Revenue	20.61%	20.67%	20.85%	20.28%	19.05%	18.34%	15.10%	15.62%	15.52%	15.73%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.49%	18.06%	20.41%	24.99%	19.33%	18.44%	15.15%	33.30%	23.42%	18.06%
Earnings before Interest and Taxes (EBIT)	254	448	420	197	680	605	742	-427	-174	203
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	323	521	500	281	769	700	835	-322	-82	284
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.62	5.58	7.09	10.20	6.69	10.91	7.28	14.59	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.21	1.59	1.74	1.36	1.52	1.84	1.50	0.55	0.78	1.37
Price to Earnings (P/E)	17.95	12.66	21.06	56.78	10.43	19.63	14.40	0.00	0.00	0.00
Dividend Yield	3.89%	2.90%	2.58%	3.28%	2.57%	1.73%	1.91%	6.79%	5.38%	3.07%
Earnings Yield	5.57%	7.90%	4.75%	1.76%	9.58%	5.10%	6.94%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.57	2.87	3.07	2.41	2.74	4.13	3.23	1.71	2.36	4.07
Enterprise Value to Revenue (EV/Rev)	1.67	2.03	2.22	2.09	2.04	2.21	1.87	1.23	1.48	1.97
Enterprise Value to EBITDA (EV/EBITDA)	12.29	9.78	11.72	19.84	8.38	13.02	11.04	0.00	0.00	24.64
Enterprise Value to EBIT (EV/EBIT)	15.63	11.39	13.95	28.24	9.48	15.06	12.44	0.00	0.00	34.40
Enterprise Value to NOPAT (EV/NOPAT)	24.90	17.75	21.47	25.38	20.95	20.55	16.70	0.00	0.00	47.85
Enterprise Value to Operating Cash Flow (EV/OCF)	16.07	20.89	16.13	16.26	28.41	16.33	33.97	0.00	9.87	10.48
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	101.14	42.12	0.00	25.02	15.40	0.00	0.00	10.55	10.84
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.83	1.66	2.12	5.61	2.28	2.16	2.26	20.11	-9.76	-5.70
Long-Term Debt to Equity	1.62	1.40	1.90	5.24	2.11	2.07	2.21	19.13	-9.57	-5.57
Financial Leverage	1.34	1.43	1.64	3.13	3.31	2.20	1.95	3.90	-43.28	-6.99
Leverage Ratio	3.82	3.86	3.94	5.68	5.62	4.49	4.77	7.84	-64.47	-9.55
Compound Leverage Factor	3.09	3.31	2.96	3.33	4.80	3.79	4.35	10.24	-167.86	1.11
Debt to Total Capital	64.65%	62.35%	67.92%	84.87%	69.55%	68.40%	69.37%	95.26%	111.41%	121.27%
Short-Term Debt to Total Capital	7.40%	9.49%	6.94%	5.58%	5.39%	2.99%	1.75%	4.63%	2.23%	2.86%
Long-Term Debt to Total Capital	57.24%	52.86%	60.99%	79.28%	64.15%	65.42%	67.62%	90.64%	109.18%	118.41%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.69%	0.98%	0.63%	0.21%	0.19%	0.26%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	34.66%	36.67%	31.45%	14.92%	30.26%	31.34%	30.63%	4.74%	-11.41%	-21.27%
Debt to EBITDA	3.59	2.33	2.80	7.19	2.15	2.17	2.75	-9.23	-31.98	7.84
Net Debt to EBITDA	3.36	2.08	2.50	6.94	2.12	2.15	2.21	-8.36	-30.46	7.43
Long-Term Debt to EBITDA	3.18	1.98	2.52	6.71	1.98	2.08	2.68	-8.78	-31.34	7.66
Debt to NOPAT	7.27	4.24	5.13	9.19	5.37	3.43	4.15	-9.78	-21.38	15.24
Net Debt to NOPAT	6.82	3.78	4.58	8.87	5.31	3.39	3.34	-8.85	-20.36	14.44
Long-Term Debt to NOPAT	6.43	3.59	4.61	8.59	4.95	3.28	4.05	-9.30	-20.95	14.88
Altman Z-Score	2.80	3.22	3.43	2.42	3.79	4.12	3.39	1.51	1.74	2.61
Noncontrolling Interest Sharing Ratio	2.16%	2.30%	2.29%	1.75%	0.88%	0.72%	0.33%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.81	1.46	1.62	1.45	1.68	1.28	1.77	2.06	1.81	1.31
Quick Ratio	0.62	0.47	0.75	0.56	0.53	0.54	0.64	0.48	0.43	0.33
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-119	50	139	-175	258	592	-97	-285	497	645
Operating Cash Flow to CapEx	439.32%	436.49%	568.39%	542.79%	562.78%	0.00%	254.45%	-256.97%	588.04%	818.01%
Free Cash Flow to Firm to Interest Expense	-2.44	0.70	1.83	-2.03	2.53	6.25	-1.22	-2.41	2.79	4.06
Operating Cash Flow to Interest Expense	5.06	3.40	4.77	3.96	2.23	5.89	3.44	-1.09	2.98	4.20
Operating Cash Flow Less CapEx to Interest Expense	3.91	2.62	3.93	3.23	1.83	6.45	2.09	-1.52	2.47	3.69
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.03	0.95	0.96	0.92	1.04	1.29	1.20	0.86	0.92	1.13
Accounts Receivable Turnover	12.42	17.61	16.27	12.57	14.03	11.83	10.28	9.10	10.40	14.77
Inventory Turnover	4.00	4.06	4.16	4.05	4.18	4.79	3.95	2.47	2.60	3.68
Fixed Asset Turnover	5.38	5.64	5.79	5.33	5.86	0.00	0.00	6.39	5.84	5.83
Accounts Payable Turnover	8.08	9.90	11.74	11.85	11.72	9.20	6.91	5.91	8.34	10.28
Days Sales Outstanding (DSO)	29.38	20.73	22.43	29.03	26.02	30.86	35.51	40.10	35.10	24.71
Days Inventory Outstanding (DIO)	91.34	89.84	87.69	90.18	87.28	76.17	92.33	147.74	140.24	99.13
Days Payable Outstanding (DPO)	45.20	36.85	31.08	30.80	31.15	39.66	52.83	61.73	43.75	35.52
Cash Conversion Cycle (CCC)	75.52	73.71	79.04	88.42	82.14	67.37	75.01	126.12	131.58	88.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,541	1,777	1,911	2,306	2,356	2,208	2,857	2,838	2,219	1,719
Invested Capital Turnover	1.69	1.51	1.43	1.26	1.35	1.81	1.94	1.38	1.40	1.80
Increase / (Decrease) in Invested Capital	279	237	134	395	50	-148	649	-19	-619	-499
Enterprise Value (EV)	3,967	5,096	5,859	5,568	6,444	9,114	9,224	4,846	5,242	6,994
Market Capitalization	2,869	3,991	4,597	3,617	4,807	7,603	7,380	2,156	2,756	4,884
Book Value per Share	$10.13	$11.80	$11.11	$6.40	$12.95	$12.50	$18.16	$2.67	($4.76)	($6.87)
Tangible Book Value per Share	($5.19)	($5.72)	($9.27)	($18.86)	($9.51)	($9.43)	($5.40)	($12.39)	($16.88)	($18.54)
Total Capital	1,791	1,950	2,063	2,376	2,375	2,224	3,308	3,118	2,342	1,836
Total Debt	1,158	1,216	1,401	2,016	1,652	1,522	2,295	2,971	2,610	2,227
Total Long-Term Debt	1,025	1,031	1,258	1,884	1,524	1,455	2,237	2,826	2,557	2,174
Net Debt	1,086	1,086	1,250	1,946	1,633	1,505	1,843	2,690	2,486	2,110
Capital Expenditures (CapEx)	56	56	64	63	40	-53	107	50	90	82
Debt-free, Cash-free Net Working Capital (DFCFNWC)	562	482	360	372	531	316	697	1,076	645	211
Debt-free Net Working Capital (DFNWC)	633	511	480	406	549	333	941	1,162	676	283
Net Working Capital (NWC)	501	326	337	273	421	266	884	1,018	624	230
Net Nonoperating Expense (NNE)	0.64	-28	54	156	-153	55	39	134	258	181
Net Nonoperating Obligations (NNO)	908	1,043	1,250	1,946	1,633	1,505	1,843	2,690	2,486	2,110
Total Depreciation and Amortization (D&A)	69	74	80	83	89	95	94	105	93	81
Debt-free, Cash-free Net Working Capital to Revenue	23.69%	19.24%	13.62%	13.96%	16.81%	7.65%	14.16%	27.41%	18.15%	5.94%
Debt-free Net Working Capital to Revenue	26.70%	20.38%	18.18%	15.23%	17.40%	8.05%	19.11%	29.62%	19.05%	7.96%
Net Working Capital to Revenue	21.11%	13.00%	12.76%	10.25%	13.35%	6.44%	17.94%	25.94%	17.57%	6.48%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.62	$5.16	$3.68	$1.13	$8.30	$6.96	$9.20	($7.88)	($6.79)	($0.61)
Adjusted Weighted Average Basic Shares Outstanding	61.51M	60.09M	57.53M	55.33M	55.82M	55.74M	55.16M	55.46M	56.55M	57.41M
Adjusted Diluted Earnings per Share	$2.57	$5.09	$3.63	$1.12	$8.18	$6.81	$8.96	($7.88)	($6.79)	($0.61)
Adjusted Weighted Average Diluted Shares Outstanding	61.51M	60.09M	57.53M	55.33M	55.82M	55.74M	55.16M	55.46M	56.55M	57.41M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	61.51M	60.09M	57.53M	55.33M	55.82M	55.74M	55.16M	55.46M	56.55M	57.41M
Normalized Net Operating Profit after Tax (NOPAT)	204	254	276	232	313	444	556	181	74	190
Normalized NOPAT Margin	8.58%	10.14%	10.45%	8.70%	9.92%	10.75%	11.28%	4.62%	2.09%	5.35%
Pre Tax Income Margin	8.65%	15.31%	11.92%	4.34%	18.43%	12.36%	13.75%	-14.22%	-12.76%	-0.66%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.20	6.24	5.52	2.28	6.68	6.39	9.40	-3.62	-0.98	1.28
NOPAT to Interest Expense	3.27	4.00	3.59	2.54	3.02	4.68	7.00	-2.57	-0.69	0.92
EBIT Less CapEx to Interest Expense	4.05	5.46	4.68	1.55	6.28	6.95	8.05	-4.04	-1.48	0.77
NOPAT Less CapEx to Interest Expense	2.11	3.22	2.75	1.81	2.63	5.24	5.65	-3.00	-1.19	0.41
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	70.13%	37.04%	58.68%	188.38%	27.05%	105.82%	27.85%	-37.99%	-39.23%	-433.52%
Augmented Payout Ratio	79.46%	80.69%	175.32%	813.81%	27.73%	119.51%	53.04%	-96.94%	-41.67%	-448.14%

This table displays calculated financial ratios and metrics derived from Scotts Miracle-Gro's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	7/2/2022	9/30/2022	12/31/2022	4/1/2023	7/1/2023	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/30/2024	12/28/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-26.32%	-33.11%	-6.96%	-8.75%	-5.68%	-24.13%	-22.07%	-0.40%	7.46%	10.73%	1.56%
EBITDA Growth	-263.31%	-1,520.66%	-72.41%	-45.30%	118.66%	-100.97%	-92.00%	27.69%	120.08%	49.89%	-15.97%
EBIT Growth	-284.90%	-519.78%	-19.64%	-47.31%	113.71%	-87.06%	-21.64%	31.89%	158.52%	47.74%	-6.95%
NOPAT Growth	-271.80%	-502.15%	-18.08%	-50.16%	116.50%	-85.76%	-13.16%	29.48%	122.35%	48.07%	-7.82%
Net Income Growth	-296.50%	-359.50%	-29.40%	-60.43%	109.84%	-112.86%	-24.42%	43.97%	202.29%	47.92%	13.66%
EPS Growth	-303.30%	-365.48%	-30.00%	-60.73%	109.61%	-113.04%	-21.37%	41.24%	196.10%	49.46%	14.79%
Operating Cash Flow Growth	-6.05%	15.04%	43.59%	64.16%	21.51%	-2.78%	20.48%	324.83%	4.51%	-77.86%	-29.75%
Free Cash Flow Firm Growth	-770.44%	79.60%	135.64%	219.91%	171.41%	338.00%	47.83%	6.17%	60.52%	6.16%	-49.85%
Invested Capital Growth	20.97%	-0.67%	-13.19%	-23.23%	-18.29%	-21.81%	-22.15%	-31.13%	-34.58%	-22.50%	-15.02%
Revenue Q/Q Growth	-29.33%	-58.38%	6.69%	190.83%	-26.95%	-66.52%	9.59%	271.69%	-21.19%	-65.50%	0.51%
EBITDA Q/Q Growth	-228.11%	63.26%	92.35%	1,619.33%	-56.30%	-495.68%	92.69%	1,110.42%	-24.67%	-190.10%	83.09%
EBIT Q/Q Growth	-243.87%	60.32%	81.93%	610.95%	-62.56%	-641.22%	88.25%	653.99%	-26.62%	-209.41%	75.95%
NOPAT Q/Q Growth	-230.33%	60.18%	81.34%	614.66%	-56.86%	-548.37%	88.63%	688.87%	-25.92%	-204.73%	76.40%
Net Income Q/Q Growth	-260.54%	50.42%	70.60%	269.09%	-60.05%	-1,172.08%	82.82%	295.65%	-16.13%	-284.71%	71.52%
EPS Q/Q Growth	-262.15%	51.19%	70.08%	265.81%	-60.31%	-1,181.82%	82.95%	292.96%	-16.79%	-284.65%	71.26%
Operating Cash Flow Q/Q Growth	222.65%	18.92%	-178.39%	68.65%	515.82%	-4.85%	-164.11%	188.64%	93.29%	-79.85%	-475.78%
Free Cash Flow Firm Q/Q Growth	-1.60%	86.61%	438.37%	160.40%	-39.49%	-55.36%	110.17%	87.02%	-8.52%	-70.48%	-0.73%
Invested Capital Q/Q Growth	-20.00%	-22.46%	14.84%	7.76%	-14.84%	-25.81%	14.35%	-4.67%	-19.11%	-12.11%	25.38%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	19.95%	-14.34%	18.17%	26.95%	18.41%	-15.22%	15.16%	30.40%	29.45%	-7.11%	22.74%
EBITDA Margin	-45.00%	-39.73%	-2.85%	14.88%	8.90%	-105.23%	-7.02%	19.08%	18.23%	-47.62%	-8.01%
Operating Margin	-47.42%	-45.38%	-7.94%	13.46%	6.91%	-111.11%	-11.53%	17.84%	16.64%	-52.11%	-12.24%
EBIT Margin	-47.28%	-45.08%	-7.63%	13.41%	6.87%	-111.13%	-11.92%	17.76%	16.54%	-52.45%	-12.55%
Profit (Net Income) Margin	-37.43%	-44.59%	-12.29%	7.14%	3.91%	-125.10%	-19.62%	10.33%	10.99%	-58.84%	-16.67%
Tax Burden Percent	76.97%	81.01%	68.61%	73.03%	84.04%	83.54%	70.49%	71.66%	72.19%	78.16%	72.47%
Interest Burden Percent	102.84%	122.11%	234.58%	72.93%	67.62%	134.74%	233.54%	81.14%	92.05%	143.54%	183.37%
Effective Tax Rate	0.00%	0.00%	0.00%	26.97%	15.96%	0.00%	0.00%	28.34%	27.81%	0.00%	0.00%
Return on Invested Capital (ROIC)	-41.40%	-43.78%	-6.16%	9.09%	6.41%	-109.25%	-9.56%	14.78%	17.06%	-65.82%	-12.99%
ROIC Less NNEP Spread (ROIC-NNEP)	-43.35%	-46.58%	-7.31%	7.91%	5.71%	-116.10%	-11.11%	13.54%	16.56%	-69.85%	-14.21%
Return on Net Nonoperating Assets (RNNOA)	-144.76%	-181.86%	-50.24%	49.58%	63.00%	5,024.44%	208.72%	-721.69%	-7,204.46%	487.96%	91.30%
Return on Equity (ROE)	-186.16%	-225.64%	-56.40%	58.67%	69.41%	4,915.18%	199.16%	-706.91%	-7,187.39%	422.15%	78.31%
Cash Return on Invested Capital (CROIC)	-24.15%	-10.00%	5.33%	15.51%	20.50%	19.66%	20.57%	34.18%	42.05%	32.78%	22.36%
Operating Return on Assets (OROA)	-41.00%	-38.89%	-6.07%	8.96%	5.34%	-102.37%	-9.92%	13.67%	14.62%	-59.29%	-12.97%
Return on Assets (ROA)	-32.45%	-38.47%	-9.76%	4.77%	3.04%	-115.24%	-16.33%	7.95%	9.72%	-66.51%	-17.24%
Return on Common Equity (ROCE)	-186.16%	-225.64%	-56.40%	58.67%	69.41%	4,915.18%	199.16%	-706.91%	-7,187.39%	422.15%	78.31%
Return on Equity Simple (ROE_SIMPLE)	-63.45%	0.00%	-760.00%	-450.40%	-97.70%	0.00%	102.72%	138.62%	177.43%	0.00%	4.98%
Net Operating Profit after Tax (NOPAT)	-394	-157	-29	151	65	-291	-33	195	144	-151	-36
NOPAT Margin	-33.20%	-31.77%	-5.56%	9.83%	5.81%	-77.78%	-8.07%	12.78%	12.02%	-36.48%	-8.57%
Net Nonoperating Expense Percent (NNEP)	1.95%	2.79%	1.16%	1.18%	0.70%	6.85%	1.55%	1.24%	0.50%	4.04%	1.22%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-1.26%	-	-	-	-1.61%
Cost of Revenue to Revenue	80.05%	114.34%	81.83%	73.05%	81.59%	115.22%	84.84%	69.60%	70.55%	107.11%	77.26%
SG&A Expenses to Revenue	11.45%	23.99%	24.40%	12.16%	11.49%	28.84%	27.97%	11.72%	12.30%	28.36%	29.94%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	67.37%	31.04%	26.11%	13.48%	11.50%	95.89%	26.68%	12.56%	12.81%	45.00%	34.98%
Earnings before Interest and Taxes (EBIT)	-561	-223	-40	205	77	-416	-49	271	199	-218	-52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-534	-196	-15	228	100	-394	-29	291	219	-198	-33
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	9.76	14.59	42.47	26.83	24.90	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.98	0.55	0.65	0.99	0.91	0.78	1.00	1.22	1.05	1.37	1.07
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	3.58%	6.79%	5.79%	4.00%	4.41%	5.38%	4.31%	3.57%	4.06%	3.07%	4.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.00	1.71	1.76	2.01	2.08	2.36	2.51	2.83	2.96	4.07	2.98
Enterprise Value to Revenue (EV/Rev)	1.76	1.23	1.47	1.89	1.69	1.48	1.85	2.00	1.65	1.97	1.81
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	53.36	0.00	0.00	0.00	66.41	24.64	23.01
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	316.92	0.00	0.00	0.00	1,260.42	34.40	32.15
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	501.34	0.00	0.00	0.00	941.23	47.85	44.76
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	28.00	15.81	11.37	9.87	10.27	6.47	5.35	10.48	11.37
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	30.64	11.26	9.11	10.55	10.68	6.77	5.57	10.84	12.25
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	8.32	20.11	57.25	25.99	22.85	-9.76	-7.85	-11.23	-17.03	-5.70	-5.61
Long-Term Debt to Equity	7.55	19.13	53.61	22.82	19.50	-9.57	-7.70	-11.00	-16.66	-5.57	-5.50
Financial Leverage	3.34	3.90	6.87	6.27	11.03	-43.28	-18.78	-53.29	-434.93	-6.99	-6.43
Leverage Ratio	6.24	7.84	10.97	10.06	17.09	-64.47	-25.31	-78.59	-696.82	-9.55	-7.96
Compound Leverage Factor	6.42	9.57	25.74	7.34	11.56	-86.87	-59.12	-63.77	-641.44	-13.71	-14.60
Debt to Total Capital	89.27%	95.26%	98.28%	96.29%	95.81%	111.41%	114.61%	109.77%	106.24%	121.27%	121.68%
Short-Term Debt to Total Capital	8.27%	4.63%	6.26%	11.73%	14.02%	2.23%	2.07%	2.25%	2.26%	2.86%	2.47%
Long-Term Debt to Total Capital	81.00%	90.64%	92.03%	84.56%	81.78%	109.18%	112.54%	107.52%	103.98%	118.41%	119.21%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	10.73%	4.74%	1.72%	3.71%	4.19%	-11.41%	-14.61%	-9.77%	-6.24%	-21.27%	-21.68%
Debt to EBITDA	-25.22	-9.23	-10.38	-6.91	26.46	-31.98	-31.69	-87.25	28.51	7.84	9.64
Net Debt to EBITDA	-23.51	-8.36	-9.75	-6.53	24.53	-30.46	-30.63	-82.64	24.08	7.43	9.44
Long-Term Debt to EBITDA	-22.88	-8.78	-9.72	-6.07	22.58	-31.34	-31.12	-85.46	27.91	7.66	9.44
Debt to NOPAT	-20.10	-9.78	-11.05	-8.21	248.55	-21.38	-24.01	-35.32	404.11	15.24	18.75
Net Debt to NOPAT	-18.73	-8.85	-10.38	-7.75	230.48	-20.36	-23.21	-33.45	341.33	14.44	18.36
Long-Term Debt to NOPAT	-18.24	-9.30	-10.35	-7.21	212.17	-20.95	-23.58	-34.59	395.52	14.88	18.37
Altman Z-Score	1.72	1.67	1.81	1.97	1.91	1.51	1.82	2.15	2.27	2.13	2.01
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.42	2.06	2.47	2.07	1.69	1.81	2.20	1.83	1.80	1.31	1.88
Quick Ratio	0.91	0.48	0.55	1.08	0.89	0.43	0.39	0.89	0.92	0.33	0.33
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,028	-138	466	1,213	734	328	689	1,288	1,178	348	345
Operating Cash Flow to CapEx	1,442.37%	0.00%	-1,458.11%	-609.46%	2,557.27%	2,817.37%	-905.54%	1,866.26%	4,454.55%	713.86%	-1,519.80%
Free Cash Flow to Firm to Interest Expense	-33.16	-3.93	10.91	25.12	15.59	8.19	16.09	29.21	30.37	10.51	10.25
Operating Cash Flow to Interest Expense	14.94	15.73	-10.11	-2.80	11.94	13.38	-8.02	6.90	15.15	3.58	-13.21
Operating Cash Flow Less CapEx to Interest Expense	13.90	16.86	-10.80	-3.26	11.48	12.91	-8.90	6.53	14.81	3.08	-14.08
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.87	0.86	0.79	0.67	0.78	0.92	0.83	0.77	0.88	1.13	1.03
Accounts Receivable Turnover	4.15	9.10	9.70	2.58	3.48	10.40	8.83	2.94	4.22	14.77	14.20
Inventory Turnover	2.61	2.47	1.91	2.25	2.64	2.60	2.09	2.82	3.61	3.68	2.57
Fixed Asset Turnover	6.90	6.39	6.43	6.18	6.04	5.84	5.71	5.73	5.91	5.83	5.85
Accounts Payable Turnover	8.17	5.91	7.64	6.64	9.22	8.34	8.04	6.44	7.88	10.28	8.34
Days Sales Outstanding (DSO)	88.02	40.10	37.64	141.23	105.03	35.10	41.33	124.26	86.48	24.71	25.70
Days Inventory Outstanding (DIO)	139.61	147.74	191.42	162.13	138.22	140.24	174.98	129.34	101.22	99.13	141.81
Days Payable Outstanding (DPO)	44.70	61.73	47.78	54.98	39.59	43.75	45.40	56.71	46.31	35.52	43.77
Cash Conversion Cycle (CCC)	182.94	126.12	181.28	248.38	203.66	131.58	170.91	196.89	141.40	88.32	123.74
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,660	2,838	3,259	3,512	2,990	2,219	2,537	2,419	1,956	1,719	2,156
Invested Capital Turnover	1.25	1.38	1.11	0.92	1.10	1.40	1.19	1.16	1.42	1.80	1.52
Increase / (Decrease) in Invested Capital	634	-19	-495	-1,063	-669	-619	-722	-1,093	-1,034	-499	-381
Enterprise Value (EV)	7,321	4,846	5,727	7,063	6,212	5,242	6,363	6,856	5,798	6,994	6,426
Market Capitalization	4,079	2,156	2,527	3,689	3,356	2,756	3,441	4,187	3,695	4,884	3,791
Book Value per Share	$7.55	$2.67	$1.07	$2.46	$2.40	($4.76)	($6.80)	($4.43)	($2.57)	($6.87)	($8.35)
Tangible Book Value per Share	($8.37)	($12.39)	($13.90)	($12.19)	($12.13)	($16.88)	($18.74)	($16.29)	($14.35)	($18.54)	($19.83)
Total Capital	3,896	3,118	3,466	3,711	3,214	2,342	2,638	2,567	2,343	1,836	2,212
Total Debt	3,478	2,971	3,406	3,573	3,080	2,610	3,024	2,818	2,489	2,227	2,692
Total Long-Term Debt	3,156	2,826	3,190	3,138	2,629	2,557	2,969	2,761	2,436	2,174	2,637
Net Debt	3,242	2,690	3,199	3,374	2,856	2,486	2,922	2,669	2,103	2,110	2,635
Capital Expenditures (CapEx)	32	-39	30	22	22	19	38	16	13	17	29
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,811	1,076	1,559	1,880	1,345	645	961	868	457	211	646
Debt-free Net Working Capital (DFNWC)	1,839	1,162	1,584	1,905	1,373	676	972	933	737	283	656
Net Working Capital (NWC)	1,517	1,018	1,368	1,470	922	624	917	875	684	230	602
Net Nonoperating Expense (NNE)	50	63	35	41	21	177	47	37	12	93	34
Net Nonoperating Obligations (NNO)	3,242	2,690	3,199	3,374	2,856	2,486	2,922	2,669	2,103	2,110	2,635
Total Depreciation and Amortization (D&A)	27	26	25	23	23	22	20	20	20	20	19
Debt-free, Cash-free Net Working Capital to Revenue	43.45%	27.41%	40.13%	50.31%	36.65%	18.15%	27.99%	25.30%	13.01%	5.94%	18.16%
Debt-free Net Working Capital to Revenue	44.11%	29.62%	40.79%	50.97%	37.40%	19.05%	28.29%	27.20%	20.98%	7.96%	18.44%
Net Working Capital to Revenue	36.39%	25.94%	35.20%	39.33%	25.12%	17.57%	26.70%	25.51%	19.47%	6.48%	16.90%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($8.01)	($3.95)	($1.17)	$1.95	$0.78	($8.35)	($1.42)	$2.77	$2.33	($4.29)	($1.21)
Adjusted Weighted Average Basic Shares Outstanding	55.40M	55.46M	55.50M	56M	56.20M	56.55M	56.70M	56.80M	56.80M	57.41M	57.30M
Adjusted Diluted Earnings per Share	($8.01)	($3.91)	($1.17)	$1.94	$0.77	($8.33)	($1.42)	$2.74	$2.28	($4.21)	($1.21)
Adjusted Weighted Average Diluted Shares Outstanding	55.40M	55.46M	55.50M	56.50M	56.60M	56.55M	56.70M	57.40M	58M	57.41M	57.30M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	55.41M	55.46M	55.96M	56.07M	56.16M	56.55M	56.69M	56.80M	56.82M	57.41M	57.47M
Normalized Net Operating Profit after Tax (NOPAT)	67	-134	-23	167	66	-117	-38	196	144	-103	-24
Normalized NOPAT Margin	5.66%	-27.12%	-4.43%	10.87%	5.93%	-31.33%	-9.28%	12.88%	11.97%	-24.90%	-5.79%
Pre Tax Income Margin	-48.62%	-55.04%	-17.91%	9.78%	4.65%	-149.75%	-27.83%	14.41%	15.22%	-75.28%	-23.01%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-18.09	-6.36	-0.94	4.25	1.63	-10.41	-1.14	6.14	5.12	-6.57	-1.55
NOPAT to Interest Expense	-12.70	-4.48	-0.69	3.12	1.38	-7.28	-0.77	4.42	3.72	-4.57	-1.06
EBIT Less CapEx to Interest Expense	-19.13	-5.23	-1.63	3.79	1.17	-10.88	-2.03	5.77	4.78	-7.07	-2.42
NOPAT Less CapEx to Interest Expense	-13.74	-3.35	-1.38	2.66	0.91	-7.76	-1.66	4.05	3.38	-5.07	-1.93
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-56.20%	-37.99%	-36.64%	-23.88%	-112.83%	-39.23%	-37.86%	-43.24%	-58.13%	-433.52%	-640.59%
Augmented Payout Ratio	-167.77%	-96.94%	-65.21%	-25.16%	-120.05%	-41.67%	-40.79%	-45.49%	-60.06%	-448.14%	-714.23%

Frequently Asked Questions About Scotts Miracle-Gro's Financials

When does Scotts Miracle-Gro's financial year end?

According to the most recent income statement we have on file, Scotts Miracle-Gro's fiscal year ends in September. Their fiscal year 2024 ended on September 30, 2024.

How has Scotts Miracle-Gro's net income changed over the last 9 years?

Scotts Miracle-Gro's net income appears to be on a downward trend, with a most recent value of -$34.90 million in 2024, falling from $158.70 million in 2015. The previous period was -$380.10 million in 2023. Check out Scotts Miracle-Gro's forecast to explore projected trends and price targets.

What is Scotts Miracle-Gro's operating income?

Scotts Miracle-Gro's total operating income in 2024 was $208.80 million, based on the following breakdown:

Total Gross Profit: $850.50 million
Total Operating Expenses: $641.70 million

How has Scotts Miracle-Gro revenue changed over the last 9 years?

Over the last 9 years, Scotts Miracle-Gro's total revenue changed from $2.37 billion in 2015 to $3.55 billion in 2024, a change of 49.8%.

How much debt does Scotts Miracle-Gro have?

Scotts Miracle-Gro's total liabilities were at $3.26 billion at the end of 2024, a 11.4% decrease from 2023, and a 72.2% increase since 2015.

How much cash does Scotts Miracle-Gro have?

In the past 9 years, Scotts Miracle-Gro's cash and equivalents has ranged from $16.60 million in 2020 to $244.10 million in 2021, and is currently $71.60 million as of their latest financial filing in 2024.

How has Scotts Miracle-Gro's book value per share changed over the last 9 years?

Over the last 9 years, Scotts Miracle-Gro's book value per share changed from 10.13 in 2015 to -6.87 in 2024, a change of -167.8%.

Related Companies

This page (NYSE:SMG) was last updated on 5/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Scotts Miracle-Gro (SMG) Financials

Frequently Asked Questions About Scotts Miracle-Gro's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Scotts Miracle-Gro (SMG) Financials

Annual Income Statements for Scotts Miracle-Gro

Quarterly Income Statements for Scotts Miracle-Gro

Annual Cash Flow Statements for Scotts Miracle-Gro

Quarterly Cash Flow Statements for Scotts Miracle-Gro

Annual Balance Sheets for Scotts Miracle-Gro

Quarterly Balance Sheets for Scotts Miracle-Gro

Annual Metrics and Ratios for Scotts Miracle-Gro

Quarterly Metrics and Ratios for Scotts Miracle-Gro

Frequently Asked Questions About Scotts Miracle-Gro's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools